Wrestling with the High Price of Cancer Care

Should We Control Costs By Individuals' Ability to Pay or Society's Willingness to Pay?

Jennifer Malin

ResearchPosted on rand.org 2010Published In: Journal of Clinical Oncology, v. 28, no. 20, Editorial, July 10, 2010, p. 3212-3214

Rising costs of cancer treatment raise questions about how to ensure that patients receive access to the best therapy that is a "good value" - both from the perspective of the patient and all who pay for health care (i.e., through taxes, insurance).

Topics

Document Details

  • Availability: Non-RAND
  • Year: 2010
  • Pages: 3
  • Document Number: EP-201000-75

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.